A prospective multi-cohort study identifies and validates a 5-gene peripheral blood signature predictive of immunotherapy response in non-small cell lung cancer.
Chen S, Liu F, Fu Y, Deng CK, Borgia JA, Ayman AG, Nasu M, Jijiwa M, Yang H, Gong T, Wang J, Ling Z, Wang X, Wang H, Chu Q, Deng Y.
Chen S, et al. Among authors: wang x, wang h, wang j.
Mol Cancer. 2024 Nov 6;23(1):247. doi: 10.1186/s12943-024-02160-2.
Mol Cancer. 2024.
PMID: 39506771
Free PMC article.